Rosa centifolia

Rosa centifolia, the cabbage rose, contains bioactive polyphenols including flavonoids (quercetin, kaempferol) and tannins (gallotannins) that drive its primary anti-inflammatory and astringent actions. These compounds inhibit pro-inflammatory mediators and exert antioxidant effects on mucosal and dermal tissues.

Origin & History

Rosa centifolia L. (cabbage rose or Provence rose) is a flowering plant from the Rosaceae family whose dried petals constitute the herbal medicinal product known as Rosae flos. The herbal substance is prepared by drying the petals or comminuting them into tiny pieces, and is recognized alongside Rosa gallica and Rosa damascena in the European Medicines Agency's Community herbal monograph.

Historical & Cultural Context

Rosa centifolia has been used in traditional medicine systems for at least 30 years with documented use in the EU for at least 15 years, qualifying it for EMA traditional use classification. The French Pharmacopoeia includes monographs on Rosa centifolia (Rose pâle) dating to 1989, and the plant is noted in Ayurvedic botanical traditions.

Health Benefits

• May help reduce mild inflammation in mouth and throat (Traditional use classification by EMA - no clinical trials available)
• Potentially soothes mild skin inflammation (Traditional use based on 30+ years of documented use - no RCT evidence)
• Demonstrated anti-inflammatory effects in animal models (64-128 mg/kg ethanol extract reduced carrageenan-induced paw edema - preclinical evidence only)
• Shows antimutagenic properties in vitro (55% reduction in ethyl methanesulfonate mutation frequency - laboratory evidence only)
• May possess antiarthritic activity (Demonstrated in animal models only - no human studies available)

How It Works

The gallotannins and flavonoids in Rosa centifolia petals inhibit cyclooxygenase (COX) enzyme activity and suppress NF-κB signaling, reducing downstream production of pro-inflammatory cytokines such as IL-6 and TNF-α. Quercetin and kaempferol also scavenge reactive oxygen species (ROS) by donating hydrogen atoms to free radicals, protecting cellular membranes from oxidative damage. Additionally, tannins form reversible protein complexes on mucosal surfaces, producing an astringent effect that reduces tissue permeability and mild local inflammation.

Scientific Research

The research dossier contains no human clinical trials, randomized controlled trials, or meta-analyses with PMIDs. The EMA's Committee on Herbal Medicinal Products has classified Rosa centifolia as a traditional herbal medicinal product based solely on long-standing use rather than modern clinical evidence, requiring documented safe use for at least 30 years including 15 years within the EU.

Clinical Summary

Human clinical evidence for Rosa centifolia is absent; the European Medicines Agency (EMA) classifies its oral and topical uses under 'traditional use' based on over 30 years of documented medicinal history rather than randomized controlled trials. Anti-inflammatory activity has been demonstrated in rodent models, where petal extracts reduced carrageenan-induced paw edema, but these findings have not been translated into human dose-response studies. No published RCTs, cohort studies, or controlled human trials with quantified outcomes currently exist for this ingredient. The evidentiary standard therefore remains preclinical and ethnobotanical, which limits confidence in efficacy claims for specific indications or dosages.

Nutritional Profile

Rosa centifolia (cabbage rose/hundred-petaled rose) is used primarily as a medicinal/aromatic botanical rather than a food ingredient, so conventional macronutrient profiling is limited. Key documented constituents include: Flavonoids (quercetin, kaempferol, rutin) at approximately 1–3% dry weight of petals — these are the primary bioactive compounds linked to anti-inflammatory activity. Polyphenols/tannins (gallotannins, ellagitannins) estimated at 2–5% dry weight, contributing to astringent properties relevant to oral and skin mucosa applications. Anthocyanins (cyanidin-3,5-diglucoside, pelargonidin derivatives) present at approximately 0.1–0.5% dry weight, responsible for pigmentation and contributing to antioxidant capacity. Volatile essential oil fraction (rose otto): 0.01–0.04% of fresh petal weight, dominated by citronellol (18–45%), geraniol (5–18%), nerol, and phenylethyl alcohol — responsible for aromatic and potential anti-inflammatory properties. Ascorbic acid (Vitamin C) is present in rose petals generally at 10–50 mg/100g fresh weight, though concentration in Rosa centifolia specifically is lower than Rosa canina hips. Carotenoids (beta-carotene, lycopene precursors) are present in trace amounts in petals (<0.1 mg/100g). Fiber content in dried petal material is approximately 15–25% dry weight (mixed soluble/insoluble), though dietary intake is negligible given typical usage doses. Protein content is low, approximately 5–8% dry weight. Bioavailability note: Flavonoid glycosides (rutin, quercetin-glucosides) require intestinal hydrolysis before absorption; bioavailability is estimated at 20–50% depending on gut microbiome composition. Tannins may reduce absorption of co-administered minerals (iron, zinc) through chelation. Volatile compounds are absorbed transdermally and via inhalation at low but pharmacologically relevant levels. Most documented use involves topical preparations (rosewater, poultices) or dilute oral rinses, where systemic nutritional contribution is negligible; bioactive effects are primarily local/topical.

Preparation & Dosage

No clinically studied dosage ranges are available from human trials. The EMA monograph references herbal tea or infusion/decoction/macerate preparations but does not specify standardized dosing protocols. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rosa damascena, Rosa gallica, Chamomile, Calendula, Marshmallow root

Safety & Interactions

Rosa centifolia is generally considered well-tolerated at traditional oral and topical doses, with no serious adverse events documented in the EMA monograph review period. High tannin intake may cause mild gastrointestinal discomfort, including nausea or constipation, particularly at elevated doses or in sensitive individuals. Due to tannin content, concurrent use with iron supplements or medications requiring optimal oral absorption (e.g., certain antibiotics, thyroid hormones) is theoretically problematic, as tannins can chelate metal ions and bind drug molecules. Safety in pregnancy, lactation, and pediatric populations has not been established through clinical study, and use in these groups should follow healthcare provider guidance.